Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptidoglycan cross-linking in Staphylococcus aureus. An apparent random polymerisation process.

M A Snowden1, H R Perkins

  • 1Glaxo Group Research Ltd, Greenford, England.

European Journal of Biochemistry
|July 31, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis case finding for vaccine trials in young children in high-incidence settings: a randomised trial.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2012
Same author

Novel glucocorticoid antedrugs possessing a 17beta-(gamma-lactone) ring.

Journal of medicinal chemistry·2001
Same author

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism.

Journal of medicinal chemistry·2000
Same author

Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle.

The Journal of biological chemistry·1998
Same author

Identification of a novel AMPK beta subunit that is highly expressed in skeletal muscle.

Biochemical Society transactions·1998
Same author

The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues.

Journal of medicinal chemistry·1996

Staphylococcus aureus peptidoglycan synthesis follows a random addition model, not monomer addition. This impacts cell wall formation, with variations observed in penicillin-binding protein mutants.

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • Staphylococcus aureus peptidoglycan features short glycan chains and extensive peptide cross-linking.
  • Understanding peptidoglycan synthesis is crucial for bacterial cell wall integrity and antibiotic development.

Purpose of the Study:

  • To investigate the polymerization model governing Staphylococcus aureus peptidoglycan cross-linking.
  • To analyze the impact of penicillin-binding protein (PBP) mutations on peptidoglycan oligomer size distribution.

Main Methods:

  • Peptidoglycan was isolated from wild-type and mutant strains of Staphylococcus aureus.
  • Hydrolysis with Chalaropsis muramidase yielded glycan-peptide fragments (monomers to oligomers).
  • High-resolution High-Performance Liquid Chromatography (HPLC) separated and identified fragments up to nonamer.

Related Experiment Videos

Main Results:

  • Oligomers up to eicosamer were detected in wild-type and most mutants, but only up to dodecamer in the PBP4- mutant (H4B).
  • Oligomer distribution profiles closely matched the random addition model, not a monomer addition model.
  • These findings suggest random addition is key for peptidoglycan cross-linking in S. aureus.

Conclusions:

  • Staphylococcus aureus peptidoglycan cross-linking predominantly follows a random addition model.
  • Penicillin-binding protein 4 (PBP4) influences the maximum size of peptidoglycan oligomers.
  • The study provides insights into bacterial cell wall synthesis and potential targets for antimicrobial strategies.